Quinolones in dermatology.
Sable
David
D
Murakawa
George J
GJ
D000890:Anti-Infective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D019540:Area Under Curve; D001424:Bacterial Infections / Q000188:drug therapy*; D001682:Biological Availability; D002939:Ciprofloxacin / Q000494:pharmacology / Q000627:therapeutic use*; D024841:Fluoroquinolones / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007408:Intestinal Absorption; D008826:Microbial Sensitivity Tests; D009268:Nalidixic Acid / Q000494:pharmacology / Q000627:therapeutic use*; D015363:Quinolones / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D012871:Skin Diseases / Q000188:drug therapy*; D013329:Structure-Activity Relationship
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; D009268:Nalidixic Acid; D002939:Ciprofloxacin; C061363:sparfloxacin